XBIT
Xbiotech·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XBIT Profile
Xbiotech Inc.
A biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases
5217 Winnebago Ln, Austin, TX 78744
--
Xbiotech Inc., incorporated in Canada on March 22, 2005, is a clinical-stage biopharmaceutical company engaged in the discovery and cultivation of "true human" monoclonal antibodies for the treatment of a variety of diseases. Real human monoclonal antibodies are those that occur naturally in humans and are not modified from animal immunization methods.
